Literature DB >> 27789675

Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome.

Christian Klemann1,2, Myrian Esquivel3,4, Aude Magerus-Chatinet3,5, Myriam R Lorenz6,7, Ilka Fuchs1, Nathalie Neveux8, Martin Castelle4, Jan Rohr1,2, Claudia Bettoni da Cunha9, Martin Ebinger10, Robin Kobbe11, Bernhard Kremens12, Florian Kollert13, Eleonora Gambineri14, Kai Lehmberg15, Markus G Seidel16, Kathrin Siepermann17, Thomas Voelker18, Volker Schuster19, Sigune Goldacker1, Klaus Schwarz6,7, Carsten Speckmann1,2, Capucine Picard3,4,20, Alain Fischer3,4,21, Frederic Rieux-Laucat3,5, Stephan Ehl1,2, Anne Rensing-Ehl22, Benedicte Neven23.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27789675      PMCID: PMC5286954          DOI: 10.3324/haematol.2016.153411

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

Authors:  Joao B Oliveira; Jack J Bleesing; Umberto Dianzani; Thomas A Fleisher; Elaine S Jaffe; Michael J Lenardo; Frederic Rieux-Laucat; Richard M Siegel; Helen C Su; David T Teachey; V Koneti Rao
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).

Authors:  David T Teachey; Dana A Obzut; Kelly Axsom; John K Choi; Kelly C Goldsmith; Junior Hall; Jessica Hulitt; Catherine S Manno; John M Maris; Nicholas Rhodin; Kathleen E Sullivan; Valerie I Brown; Stephan A Grupp
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

3.  Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome.

Authors:  Ales Janda; Klaus Schwarz; Mirjam van der Burg; Werner Vach; Hanna Ijspeert; Myriam Ricarda Lorenz; Magdeldin Elgizouli; Kathrin Pieper; Paul Fisch; Joachim Hagel; Raquel Lorenzetti; Maximilian Seidl; Joachim Roesler; Fabian Hauck; Elisabetta Traggiai; Carsten Speckmann; Anne Rensing-Ehl; Stephan Ehl; Hermann Eibel; Marta Rizzi
Journal:  Blood       Date:  2016-02-23       Impact factor: 22.113

4.  Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia.

Authors:  Anne Rensing-Ehl; Ales Janda; Myriam R Lorenz; Beryl P Gladstone; Ilka Fuchs; Mario Abinun; Michael Albert; Karina Butler; Andrew Cant; Anna-Maria Cseh; Martin Ebinger; Sigune Goldacker; Sophie Hambleton; Holger Hebart; Leonora Houet; Karim Kentouche; Ingrid Kühnle; Kai Lehmberg; Ester Mejstrikova; Charlotte Niemeyer; Milen Minkov; Olaf Neth; Gregor Dückers; Stephan Owens; Joachim Rösler; Freimut H Schilling; Volker Schuster; Markus G Seidel; Petr Smisek; Martina Sukova; Peter Svec; Thomas Wiesel; Benjamin Gathmann; Klaus Schwarz; Werner Vach; Stephan Ehl; Carsten Speckmann
Journal:  Haematologica       Date:  2013-07-12       Impact factor: 9.941

5.  FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.

Authors:  Aude Magerus-Chatinet; Marie-Claude Stolzenberg; Maria S Loffredo; Bénédicte Neven; Catherine Schaffner; Nicolas Ducrot; Peter D Arkwright; Brigitte Bader-Meunier; José Barbot; Stéphane Blanche; Jean-Laurent Casanova; Marianne Debré; Alina Ferster; Claire Fieschi; Benoit Florkin; Claire Galambrun; Olivier Hermine; Olivier Lambotte; Eric Solary; Caroline Thomas; Francoise Le Deist; Capucine Picard; Alain Fischer; Frédéric Rieux-Laucat
Journal:  Blood       Date:  2009-01-27       Impact factor: 22.113

6.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

7.  A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

Authors:  M C Sneller; S E Straus; E S Jaffe; J S Jaffe; T A Fleisher; M Stetler-Stevenson; W Strober
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

8.  Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome.

Authors:  Simon Völkl; Anne Rensing-Ehl; Andrea Allgäuer; Elisabeth Schreiner; Myriam Ricarda Lorenz; Jan Rohr; Christian Klemann; Ilka Fuchs; Volker Schuster; André O von Bueren; Nora Naumann-Bartsch; Eleonora Gambineri; Kathrin Siepermann; Robin Kobbe; Michaela Nathrath; Peter D Arkwright; Maurizio Miano; Klaus-Daniel Stachel; Markus Metzler; Klaus Schwarz; Anita N Kremer; Carsten Speckmann; Stephan Ehl; Andreas Mackensen
Journal:  Blood       Date:  2016-04-20       Impact factor: 22.113

9.  Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.

Authors:  Anne Rensing-Ehl; Simon Völkl; Carsten Speckmann; Myriam Ricarda Lorenz; Julia Ritter; Ales Janda; Mario Abinun; Hanspeter Pircher; Bertram Bengsch; Robert Thimme; Ilka Fuchs; Sandra Ammann; Andrea Allgäuer; Karim Kentouche; Andrew Cant; Sophie Hambleton; Claudia Bettoni da Cunha; Sebastian Huetker; Ingrid Kühnle; Arnulf Pekrun; Markus G Seidel; Michael Hummel; Andreas Mackensen; Klaus Schwarz; Stephan Ehl
Journal:  Blood       Date:  2014-06-03       Impact factor: 22.113

10.  Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.

Authors:  Karen L Bride; Tiffaney Vincent; Kim Smith-Whitley; Michele P Lambert; Jack J Bleesing; Alix E Seif; Catherine S Manno; James Casper; Stephan A Grupp; David T Teachey
Journal:  Blood       Date:  2015-10-26       Impact factor: 22.113

View more
  12 in total

1.  Lymphadenopathy driven by TCR-Vγ8Vδ1 T-cell expansion in FAS-related autoimmune lymphoproliferative syndrome.

Authors:  Stefano Vavassori; Jacob D Galson; Johannes Trück; Anke van den Berg; Rienk Y J Tamminga; Aude Magerus-Chatinet; Olivier Pellé; Ulrike Camenisch Gross; Ewerton Marques Maggio; Seraina Prader; Lennart Opitz; Ursina Nüesch; Andrea Mauracher; Benjamin Volkmer; Oliver Speer; Luzia Suda; Benno Röthlisberger; Dieter Robert Zimmermann; Rouven Müller; Arjan Diepstra; Lydia Visser; Eugenia Haralambieva; Bénédicte Neven; Frédéric Rieux-Laucat; Jana Pachlopnik Schmid
Journal:  Blood Adv       Date:  2017-06-22

Review 2.  The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.

Authors:  Frédéric Rieux-Laucat; Aude Magérus-Chatinet; Bénédicte Neven
Journal:  J Clin Immunol       Date:  2018-06-17       Impact factor: 8.317

Review 3.  Autoimmune lymphoproliferative syndrome: more than a FAScinating disease.

Authors:  Karen Bride; David Teachey
Journal:  F1000Res       Date:  2017-11-01

4.  Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry.

Authors:  Maria Elena Maccari; Hassan Abolhassani; Asghar Aghamohammadi; Alessandro Aiuti; Olga Aleinikova; Catherine Bangs; Safa Baris; Federica Barzaghi; Helen Baxendale; Matthew Buckland; Siobhan O Burns; Caterina Cancrini; Andrew Cant; Pascal Cathébras; Marina Cavazzana; Anita Chandra; Francesca Conti; Tanya Coulter; Lisa A Devlin; J David M Edgar; Saul Faust; Alain Fischer; Marina Garcia-Prat; Lennart Hammarström; Maximilian Heeg; Stephen Jolles; Elif Karakoc-Aydiner; Gerhard Kindle; Ayca Kiykim; Dinakantha Kumararatne; Bodo Grimbacher; Hilary Longhurst; Nizar Mahlaoui; Tomas Milota; Fernando Moreira; Despina Moshous; Anna Mukhina; Olaf Neth; Benedicte Neven; Alexandra Nieters; Peter Olbrich; Ahmet Ozen; Jana Pachlopnik Schmid; Capucine Picard; Seraina Prader; William Rae; Janine Reichenbach; Stephan Rusch; Sinisa Savic; Alessia Scarselli; Raphael Scheible; Anna Sediva; Svetlana O Sharapova; Anna Shcherbina; Mary Slatter; Pere Soler-Palacin; Aurelie Stanislas; Felipe Suarez; Francesca Tucci; Annette Uhlmann; Joris van Montfrans; Klaus Warnatz; Anthony Peter Williams; Phil Wood; Sven Kracker; Alison Mary Condliffe; Stephan Ehl
Journal:  Front Immunol       Date:  2018-03-16       Impact factor: 7.561

5.  Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation.

Authors:  Fabienne Mazerolles; Marie-Claude Stolzenberg; Olivier Pelle; Capucine Picard; Benedicte Neven; Alain Fischer; Aude Magerus-Chatinet; Frederic Rieux-Laucat
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

6.  Case Report: A Novel Pathogenic Missense Mutation in FAS: A Multi-Generational Case Series of Autoimmune Lymphoproliferative Syndrome.

Authors:  Claudia L Gaefke; Jonathan Metts; Donya Imanirad; Daime Nieves; Paola Terranova; Gianluca Dell'Orso; Eleonora Gambineri; Maurizio Miano; Richard F Lockey; Jolan Eszter Walter; Emma Westermann-Clark
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

7.  Case Report: Sirolimus Alleviates Persistent Cytopenia After CD19 CAR-T-Cell Therapy.

Authors:  Limin Xing; Yihao Wang; Hui Liu; Shan Gao; Qing Shao; Lanzhu Yue; Zhaoyun Liu; Huaquan Wang; Zonghong Shao; Rong Fu
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

8.  Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies.

Authors:  Francesco Rispoli; Erica Valencic; Martina Girardelli; Alessia Pin; Alessandra Tesser; Elisa Piscianz; Valentina Boz; Flavio Faletra; Giovanni Maria Severini; Andrea Taddio; Alberto Tommasini
Journal:  Diagnostics (Basel)       Date:  2021-03-16

9.  Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease.

Authors:  Kun Yang; Jie Han; Mayumi Asada; Jennifer G Gill; Jason Y Park; Meghana N Sathe; Jyothsna Gattineni; Tracey Wright; Christian A Wysocki; M Teresa de la Morena; Luis A Garza; Nan Yan
Journal:  J Clin Invest       Date:  2022-01-18       Impact factor: 14.808

10.  Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study.

Authors:  Ebe Schiavo; Beatrice Martini; Enrico Attardi; Filippo Consonni; Sara Ciullini Mannurita; Maria Luisa Coniglio; Marco Tellini; Elena Chiocca; Ilaria Fotzi; Laura Luti; Irene D'Alba; Marinella Veltroni; Claudio Favre; Eleonora Gambineri
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.